Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood Pressure

• Publication date

  2016-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/08037051.2015.1110922PMID 26873621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First-line drugs for hypertension.

  2018cited by this paper
• [Factors associated with poor blood pressure control in 253 treated hypertensive patients].

  2015cited by this paper
• Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies

  2014cited by this paper
• Control of hypertension with medication: a comparative analysis of national surveys in 20 countries.

  2014cited by this paper
• Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management

  2014cited by this paper
• Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA).

  2014cited by this paper
• [Economy, costs and drug choices in cardiology. A reflection on the 2012 position paper of the Italian Society of Hypertension].

  2013cited by this paper
• Global Brief on Hypertension: Silent Killer, Global Public Health Crisis

  2013cited by this paper
• [Prevalence of hypertension in El-Menia oasis, Algeria, and metabolic characteristics in population].

  2013cited by this paper
• Prevalence, Awareness, Treatment, and Control of Hypertension in United States Counties, 2001–2009

  2013cited by this paper
• Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.

  2013cited by this paper
• Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure.

  2012cited by this paper
• Lay perspectives on hypertension and drug adherence: systematic review of qualitative research

  2012cited by this paper
• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end

  2012cited by this paper
• [Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension].

  2012cited by this paper
• I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-e

  2012cited by this paper
• Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.

  2011cited by this paper
• Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension

  2011cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure

  2011cited by this paper
• Belgian global implementation of cardiovascular and stroke risk assessment study: methods and baseline data of the BELGICA-STROKE STUDY

  2011cited by this paper
• Physician Perception of Blood Pressure Control and Treatment Behavior in High-Risk Hypertensive Patients: A Cross-Sectional Study

  2011cited by this paper
• Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey

  2011cited by this paper
• High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study

  2011cited by this paper
• Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy

  2010influential reference
• Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.

  2010cited by this paper
• Optimizing blood pressure control through the use of fixed combinations

  2010cited by this paper
• Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertension

  2010cited by this paper
• Physician reported perception in the treatment of high blood pressure does not correspond to practice

  2009cited by this paper
• Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries

  2009cited by this paper
• The global cost of nonoptimal blood pressure

  2009cited by this paper
• First-line drugs for hypertension.

  2009cited by this paper
• Managing hypertension using combination therapy.

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Barriers to Optimal Hypertension Control

  2008cited by this paper
• Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey

  2008cited by this paper
• The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.

  2008cited by this paper
• Identifying Barriers to Hypertension Care: Implications for Quality Improvement Initiatives

  2008cited by this paper
• The Accuracy of Clinician Perceptions of “Usual” Blood Pressure Control

  2008influential reference
• [Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study].

  2007cited by this paper
• Frequency of analgesic use and risk of hypertension among men.

  2007cited by this paper
• Does Knowledge Matter?: Intentional Medication Nonadherence Among Middle-Aged Korean Americans With High Blood Pressure

  2007influential reference
• Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.

  2007cited by this paper
• Perfil de riesgo cardiovascular de los pacientes con hipertensión arterial no controlada. Estudio Control-Project

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan

  2007cited by this paper
• 2007 Guidelines for the management of arterial hypertension

  2007cited by this paper
• Prevention of Cardiovascular Events With an Antihypertensive Regimen of Amlodipine Adding Perindopril as Required Versus Atenolol Adding Bendroflumethiazide as Required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A Multicentre Randomised Controlled Tri

  2006cited by this paper
• Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.

  2006cited by this paper
• Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals

  2006cited by this paper
• Improvement in hypertension management in England: results from the Health Survey for England 2003

  2006cited by this paper
• Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension: Clinical Diagnosis and Indications for Revascularization

  2006cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Hypertension knowledge, awareness, and attitudes in a hypertensive population

  2005cited by this paper
• Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women

  2005cited by this paper
• Measuring Adherence to Practice Guidelines for the Management of Hypertension: An Evaluation of the Literature

  2004cited by this paper
• Hypertension Treatment and Control in Five European Countries, Canada, and the United States

  2004cited by this paper
• Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

  2004cited by this paper
• Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care

  2004cited by this paper
• Physician-Related Barriers to Hypertension Management

  2004cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group--quality of care and outcomes in type 2 diabetes.

  2003cited by this paper
• Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy

  2003cited by this paper
• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Physician-related barriers to the effective management of uncontrolled hypertension.

  2002cited by this paper
• Why do GPs not implement evidence-based guidelines? A descriptive study.

  2001cited by this paper
• Patient adherence to treatment: three decades of research. A comprehensive review

  2001cited by this paper
• Predictors of Uncontrolled Hypertension in Ambulatory Patients

  2001cited by this paper
• Characteristics of patients with uncontrolled hypertension in the United States.

  2001cited by this paper
• When should hypertension be treated? The different perspectives of Canadian family physicians and patients.

  2000cited by this paper
• Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.

  2000cited by this paper
• Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP).

  1999cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Low‐Dose Combination Treatment for Hypertension Versus Single‐Drug TreatmentBisoprolol/Hydrochlorothiazide Versus Amlodipine, Enalapril, and Placebo: Combined Analysis of Comparative Studies

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper

• [Vascular age and cardiovascular risk in hypertensive patients followed at the heart institute].

  2023cites this paper
• A Randomized Controlled Trial of Blood Pressure Reduction Based on Disease Control Priorities 3 in Pakistan to Manage and Control Hypertension

  2023cites this paper
• HYPERTENSION: A SUFFIECIENT RISK FACTOR FOR CARDIOVASCULAR DISEASES

  2021cites this paper
• A Randomized Controlled Trial Study on Hypertension Reduction Based on Disease Control Priorities to Manage High Blood Pressure

  2021cites this paper
• Salt intake and salt‐reduction strategies in South Asia: From evidence to action

  2021cites this paper
• Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study

  2020cites this paper
• The cascade of care in managing hypertension in the Arab world: a systematic assessment of the evidence on awareness, treatment and control

  2020cites this paper
• [Arterial Hypertension register in private clinics in Venezuela: RHAVEN Study].

  2019cites this paper
• Analysis of blood pressure control in outpatients with non-dialysis chronic kidney disease referred by primary care physicians: a study from the centre of nephrology care

  2019cites this paper
• Global Clinical Consequences of Poor Adherence

  2018cites this paper
• Number 206 Sodium and Potassium Intake : Effects on Chronic Disease Outcomes and Risk s Evidence Summary

  2018cites this paper
• Hypertension in Latin America: Current perspectives on trends and characteristics.

  2017cites this paper
• Effectiveness of an interventional program for the management of hypertension through strengthening of the health care delivery system : a pilot study

  2016influential citation